E-LIB Suche - Ergebnisse für: Verhoef, T I

1

Age-stratified outcome of a genotype-guided dosing algorith..:

Zhang, Y. ; de Boer, A. ; Verhoef, T. I....
Journal of Thrombosis and Haemostasis. 15 (2017) 3 - p. 454-464 , 2017

Link: https://doi.org/10.1111/..

2

Dosing algorithms for vitamin K antagonists acrossVKORC1and..:

Baranova, E. V. ; Verhoef, T. I. ; Ragia, G....
Journal of Thrombosis and Haemostasis. 15 (2017) 3 - p. 465-472 , 2017

Link: https://doi.org/10.1111/..

3

Cost-effectiveness of pharmacogenetic-guided dosing of warf..:

Verhoef, T I ; Redekop, W K ; Langenskiold, S...
The Pharmacogenomics Journal. 16 (2016) 5 - p. 478-484 , 2016

Link: https://doi.org/10.1038/..

4

Patients Benefit From Genetics-Guided Coumarin Anticoagulan..:

Zee, A H Maitland-van der ; Daly, A K ; Kamali, F...
Clinical Pharmacology & Therapeutics. 96 (2014) 1 - p. 15-17 , 2014

Link: https://doi.org/10.1038/..

5

Long-term anticoagulant effects of CYP2C9 and VKORC1 genoty..:

VERHOEF, T. I. ; REDEKOP, W. K. ; HEGAZY, H....
Journal of Thrombosis and Haemostasis. 10 (2012) 12 - p. 2610-2612 , 2012

Link: https://doi.org/10.1111/..

6

Long-term anticoagulant effects of the CYP2C9 and VKORC1 ge..:

VERHOEF, T. I. ; REDEKOP, W. K. ; BUIKEMA, M. M....
Journal of Thrombosis and Haemostasis. 10 (2012) 4 - p. 606-614 , 2012

Link: https://doi.org/10.1111/..

7

An evaluation of gene-gene interaction between the CYP2C9 a..:

VAN SCHIE, R. M. F. ; BABAJEFF, A. M. V. ; SCHALEKAMP, T....
Journal of Thrombosis and Haemostasis. 10 (2012) 5 - p. 767-772 , 2012

Link: https://doi.org/10.1111/..

8

Cost-effectiveness of a domestic violence and abuse trainin..:

Barbosa Capelas, E ; Verhoef, T. I ; Morris, S...
https://openaccess.city.ac.uk/id/eprint/26056/1/Cost-effectiveness%20of%20a%20domestic%20violence%20and%20abuse%20training%20and%20support%20programme%20in%20primary%20care%20in%20the%20real%20world%20updated.pdf. , 2018

Link: https://openaccess.city...

9

Personalised treatment with oral anticoagulant drugs : clin..:

Verhoef, T.I
https://dspace.library.uu.nl/handle/1874/286212. , 2013

Link: https://dspace.library.u..

10

Cost Effectiveness of New Oral Anticoagulants for Stroke Pr..:

Verhoef, T.I. (Talitha) ; Redekop, W.K. (Ken) ; Hasrat, F. (Fazila)..
http://repub.eur.nl/pub/87887. , 2014

Link: http://repub.eur.nl/pub/..

11

A randomized trial of genotype-guided dosing of acenocoumar..:

Verhoef, T.I. (Talitha) ; Ragia, G. (Georgia) ; Boer, A.C. (Anton) de...
http://repub.eur.nl/pub/71399. , 2013

Link: http://repub.eur.nl/pub/..

12

Long-term anticoagulant effects of CYP2C9 and VKORC1 genoty..:

Verhoef, T.I. (Talitha) ; Redekop, W.K. (Ken) ; Hegazy, H..
info:eu-repo/grantAgreement/EC/FP7/223062. , 2012

Link: http://repub.eur.nl/pub/..

13

Future of Pharmacogenetics in Cardiovascular Diseases:

Schie, R.F.M. (Rianne) van ; Verhoef, T.I. (Talitha) ; Maitland-van der Zee, A-H. (Anke-Hilse)...
http://repub.eur.nl/pub/38360. , 2012

Link: http://repub.eur.nl/pub/..

14

Clinical and economic consequences of pharmacogenetic-guide..:

Verhoef, T.I. (Talitha) ; Schalekamp, T. (Talitha) ; Redekop, W.K. (Ken)..
http://repub.eur.nl/pub/21095. , 2010

Link: http://repub.eur.nl/pub/..

15

Genotype-guided dosing of coumarin derivatives: the Europea..:

Schie, R.F.M. (Rianne) van ; Wadelius, M. (Mia) ; Kamali, F. (Farhad)...
info:eu-repo/grantAgreement/EC/FP7/223062. , 2009

Link: http://repub.eur.nl/pub/..